
Deanna L. Pratt
Examiner (ID: 3454, Phone: (571)272-7649 , Office: P/2911 )
| Most Active Art Unit | 2911 |
| Art Unit(s) | 2931, 2911 |
| Total Applications | 2897 |
| Issued Applications | 2827 |
| Pending Applications | 10 |
| Abandoned Applications | 66 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5786393
[patent_doc_number] => 20060205634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease'
[patent_app_type] => utility
[patent_app_number] => 11/401206
[patent_app_country] => US
[patent_app_date] => 2006-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10487
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205634.pdf
[firstpage_image] =>[orig_patent_app_number] => 11401206
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/401206 | Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease | Apr 9, 2006 | Abandoned |
Array
(
[id] => 5663317
[patent_doc_number] => 20060253913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Production of hSA-linked butyrylcholinesterases in transgenic mammals'
[patent_app_type] => utility
[patent_app_number] => 11/401390
[patent_app_country] => US
[patent_app_date] => 2006-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 40621
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20060253913.pdf
[firstpage_image] =>[orig_patent_app_number] => 11401390
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/401390 | Production of hSA-linked butyrylcholinesterases in transgenic mammals | Apr 9, 2006 | Abandoned |
Array
(
[id] => 4822949
[patent_doc_number] => 20080227691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Blood Coagulation FVIII Analogues'
[patent_app_type] => utility
[patent_app_number] => 11/910349
[patent_app_country] => US
[patent_app_date] => 2006-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13804
[patent_no_of_claims] => 547
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227691.pdf
[firstpage_image] =>[orig_patent_app_number] => 11910349
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910349 | Blood Coagulation FVIII Analogues | Apr 2, 2006 | Abandoned |
Array
(
[id] => 602589
[patent_doc_number] => 07432352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-07
[patent_title] => 'Hybrid molecules having Factor VII/VIIa activity'
[patent_app_type] => utility
[patent_app_number] => 11/393327
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 1
[patent_no_of_words] => 17613
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/432/07432352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11393327
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/393327 | Hybrid molecules having Factor VII/VIIa activity | Mar 29, 2006 | Issued |
Array
(
[id] => 5106960
[patent_doc_number] => 20070065838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'OLIGONUCLEOTIDE MEDIATED NUCLEIC ACID RECOMBINATION'
[patent_app_type] => utility
[patent_app_number] => 11/277337
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22681
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065838.pdf
[firstpage_image] =>[orig_patent_app_number] => 11277337
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/277337 | OLIGONUCLEOTIDE MEDIATED NUCLEIC ACID RECOMBINATION | Mar 22, 2006 | Abandoned |
Array
(
[id] => 5625868
[patent_doc_number] => 20060264373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Modified vitamin K-dependent polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/377904
[patent_app_country] => US
[patent_app_date] => 2006-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 24392
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264373.pdf
[firstpage_image] =>[orig_patent_app_number] => 11377904
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/377904 | Modified vitamin K-dependent polypeptides | Mar 15, 2006 | Abandoned |
Array
(
[id] => 5626111
[patent_doc_number] => 20060264616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Modified vitamin K-dependent polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/377620
[patent_app_country] => US
[patent_app_date] => 2006-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21834
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264616.pdf
[firstpage_image] =>[orig_patent_app_number] => 11377620
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/377620 | Modified vitamin K-dependent polypeptides | Mar 15, 2006 | Issued |
Array
(
[id] => 5337304
[patent_doc_number] => 20090053768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Novel Phospholipase C Enzyme (S)'
[patent_app_type] => utility
[patent_app_number] => 12/224867
[patent_app_country] => US
[patent_app_date] => 2006-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12371
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053768.pdf
[firstpage_image] =>[orig_patent_app_number] => 12224867
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/224867 | Phospholipase C enzyme(s) | Mar 9, 2006 | Issued |
Array
(
[id] => 5859774
[patent_doc_number] => 20060229250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Ghrelin associated peptide and its uses'
[patent_app_type] => utility
[patent_app_number] => 11/372888
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13066
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11372888
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/372888 | Ghrelin associated peptide and its uses | Mar 8, 2006 | Abandoned |
Array
(
[id] => 5034636
[patent_doc_number] => 20070099175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Modified fluorescent proteins'
[patent_app_type] => utility
[patent_app_number] => 11/371240
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19981
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099175.pdf
[firstpage_image] =>[orig_patent_app_number] => 11371240
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/371240 | Modified fluorescent proteins | Mar 8, 2006 | Abandoned |
Array
(
[id] => 5834712
[patent_doc_number] => 20060246543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Slim compositions and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/368166
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 55090
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246543.pdf
[firstpage_image] =>[orig_patent_app_number] => 11368166
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/368166 | Slim compositions and methods of use thereof | Mar 2, 2006 | Abandoned |
Array
(
[id] => 4792107
[patent_doc_number] => 20080293081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Fluorescence Polarization Assays for Acetyltransferase/Deacetylase Activity'
[patent_app_type] => utility
[patent_app_number] => 11/885390
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19280
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293081.pdf
[firstpage_image] =>[orig_patent_app_number] => 11885390
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885390 | Fluorescence Polarization Assays for Acetyltransferase/Deacetylase Activity | Mar 2, 2006 | Abandoned |
Array
(
[id] => 5785355
[patent_doc_number] => 20060205036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Coagulation Factor VII polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/367189
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 29305
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205036.pdf
[firstpage_image] =>[orig_patent_app_number] => 11367189
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/367189 | Coagulation Factor VII polypeptides | Mar 2, 2006 | Abandoned |
Array
(
[id] => 5753941
[patent_doc_number] => 20060223090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Polynucleotides encoding human secreted proteins'
[patent_app_type] => utility
[patent_app_number] => 11/366980
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 283049
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223090.pdf
[firstpage_image] =>[orig_patent_app_number] => 11366980
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/366980 | Polynucleotides encoding human secreted proteins | Mar 2, 2006 | Abandoned |
Array
(
[id] => 5028891
[patent_doc_number] => 20070270338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/365484
[patent_app_country] => US
[patent_app_date] => 2006-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14574
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270338.pdf
[firstpage_image] =>[orig_patent_app_number] => 11365484
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/365484 | pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof | Feb 28, 2006 | Issued |
Array
(
[id] => 5277954
[patent_doc_number] => 20090130086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'FXIII Variants with Improved Properties'
[patent_app_type] => utility
[patent_app_number] => 11/817039
[patent_app_country] => US
[patent_app_date] => 2006-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9993
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130086.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817039
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817039 | FXIII Variants with Improved Properties | Feb 26, 2006 | Abandoned |
Array
(
[id] => 5580941
[patent_doc_number] => 20090176287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'PRODUCING CAROTENOIDS'
[patent_app_type] => utility
[patent_app_number] => 11/817120
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 20138
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176287.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817120
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817120 | PRODUCING CAROTENOIDS | Feb 23, 2006 | Abandoned |
Array
(
[id] => 8458045
[patent_doc_number] => 08293710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-23
[patent_title] => 'Method for treating wounds using an EGF-like domain of thrombomodulin'
[patent_app_type] => utility
[patent_app_number] => 11/361560
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 7116
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11361560
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/361560 | Method for treating wounds using an EGF-like domain of thrombomodulin | Feb 23, 2006 | Issued |
Array
(
[id] => 5296527
[patent_doc_number] => 20090011453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Methods for Producing Proteins Using Hamster Igf-1'
[patent_app_type] => utility
[patent_app_number] => 11/884538
[patent_app_country] => US
[patent_app_date] => 2006-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11144
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0011/20090011453.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884538
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884538 | Nucleic acids encoding hamster 1GF-1 proteins and methods thereof | Feb 20, 2006 | Issued |
Array
(
[id] => 5303510
[patent_doc_number] => 20090298162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'BIOSENSORS FOR MONITORING RECEPTOR-MEDIATED G-PROTEIN ACTIVATION'
[patent_app_type] => utility
[patent_app_number] => 11/816517
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 18398
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298162.pdf
[firstpage_image] =>[orig_patent_app_number] => 11816517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/816517 | Biosensors for monitoring receptor-mediated G-protein activation | Feb 15, 2006 | Issued |